DIGITAL HEALTH NAVIGATION SOLUTIONS, LLC

WINSTON SALEM, NC

OncologyGrant-only

Compare Sign in to watch

What changed

NIH R01 · $0.4M · Homeobox Genes and Neuron Identity Control on a Brain-Wide Level

6w agoGrant renewalJun 3, 2026Source filing (opens the source filing in a new tab)

Momentum

83no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

10,139 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
P20 · $210k · non-dilutive
May 15, 2026
UNIVERSITY OF OKLAHOMA · PI MILLER, DAVID ROGER · NIGMS · award ends Jan 31, 2031 · Neuroimaging-guided Immunotherapy for Glioblastoma
NIH RePORTER · NIH RePORTER 11269427 (opens the source filing in a new tab)
Grant
R01 · $614k · non-dilutive
May 15, 2026
VANDERBILT UNIVERSITY · PI MILLER, DAVID M · NINDS · award ends Feb 28, 2031 · Molecular genetics of synaptic remodeling
NIH RePORTER · NIH RePORTER 11368183 (opens the source filing in a new tab)
Grant
OT2 · $183k · non-dilutive
May 1, 2026
YALE UNIVERSITY · PI KRISHNASWAMY, SMITA · NCI · award ends Apr 30, 2027 · Rewire-CAN-Therapeutic Rewiring of Colorectal Cancer
NIH RePORTER · NIH RePORTER 11505210 (opens the source filing in a new tab)
Trial
NA registered
Jun 9, 2025
Colorectal Cancer Screening · ACTIVE_NOT_RECRUITING · sponsor: Digital Health Navigation Solutions, Inc · Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
ClinicalTrials.gov · NCT06821009 (opens the source filing in a new tab)
Grant
R01 · $411k · non-dilutive
Mar 15, 2024
COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HOBERT, OLIVER · NINDS · award ends Feb 28, 2029 · Regulatory Architecture of Glia Cell Type Diversity in C. Elegans
NIH RePORTER · NIH RePORTER 11285299 (opens the source filing in a new tab)
Grant
R42 · $1.0M · non-dilutive
Apr 1, 2023
DIGITAL HEALTH NAVIGATION SOLUTIONS, LLC · PI MILLER, DAVID P · NCI · award ends Jun 30, 2027 · A cloud-based digital health navigation program for colorectal cancer screening
NIH RePORTER · NIH RePORTER 11146650 (opens the source filing in a new tab)
Grant
R01 · $341k · non-dilutive
Sep 4, 2018
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI MILLER, DAVID JOEL · NICHD · award ends Jun 30, 2028 · Accumulation, Storage, and Release of Sperm in the Oviduct
NIH RePORTER · NIH RePORTER 11160742 (opens the source filing in a new tab)
Grant
R01 · $1.3M · non-dilutive
Sep 25, 2017
YALE UNIVERSITY · PI HAMMARLUND, MARC · NINDS · award ends Dec 31, 2027 · Discovery and analysis of the C. elegans neuronal gene expression network (CeNGEN)
NIH RePORTER · NIH RePORTER 11257678 (opens the source filing in a new tab)
Grant
R01 · $369k · non-dilutive
Apr 1, 2001
COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HOBERT, OLIVER · NINDS · award ends May 31, 2027 · Homeobox Genes and Neuron Identity Control on a Brain-Wide Level
NIH RePORTER · NIH RePORTER 11360638 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.99name similarity 100% · semantic similarity 87% · shared principal investigator / founder · same therapeutic area
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the grant record at 0.26same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R01 · $0.4M · Homeobox Genes and Neuron Identity Control on a Brain-Wide Level
6w agoGrant renewalSource (opens the source filing in a new tab)
NIH OT2 · $0.2M · Rewire-CAN-Therapeutic Rewiring of Colorectal Cancer
6w agoNew grantSource (opens the source filing in a new tab)
NIH P20 · $0.2M · Neuroimaging-guided Immunotherapy for Glioblastoma
2mo agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Molecular genetics of synaptic remodeling
2mo agoNew grantSource (opens the source filing in a new tab)
Study registered, no phase assigned: Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
2mo agoTrial registeredSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Regulatory Architecture of Glia Cell Type Diversity in C. Elegans
5mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $1.3M · Discovery and analysis of the C. elegans neuronal gene expression network (CeNGEN)
5mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.3M · Accumulation, Storage, and Release of Sperm in the Oviduct
Jul 2025Grant renewalSource (opens the source filing in a new tab)
NIH R42 · $1.0M · A cloud-based digital health navigation program for colorectal cancer screening
Jul 2025Grant renewalSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

P20 · $210k · non-dilutive

R01 · $614k · non-dilutive

OT2 · $183k · non-dilutive

NA registered

R01 · $411k · non-dilutive

R42 · $1.0M · non-dilutive

R01 · $341k · non-dilutive

R01 · $1.3M · non-dilutive

R01 · $369k · non-dilutive